Notis Mc Conarty Edward Amgen Inc Transaction History

Notis Mc Conarty Edward

$252 Million
Q2 2024

A detailed history of Notis Mc Conarty Edward transactions in Amgen Inc stock. As of the latest transaction made, Notis Mc Conarty Edward holds 4,075 shares of AMGN stock, worth $1.31 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

4,075

Previous 4,340 6.11%

Holding current value

$1.31 Million

Previous $1.23 Million 3.24%

% of portfolio

0.51%

Previous 0.49%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $69,628 - $84,617	-265 Reduced 6.11%	4,075 $1.27 Million
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $199,770 - $241,148	-743 Reduced 14.62%	4,340 $1.23 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $153,420 - $173,076	-600 Reduced 10.56%	5,083 $1.46 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $184,759 - $229,383	-845 Reduced 12.94%	5,683 $1.53 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $3,386 - $4,128	-15 Reduced 0.23%	6,528 $1.58 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $45,806 - $58,202	-200 Reduced 2.97%	6,543 $1.72 Million
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $78,561 - $88,602	-350 Reduced 4.93%	6,743 $1.52 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $168,418 - $187,420	-730 Reduced 9.33%	7,093 $1.73 Million
Q1 2022 May 17, 2022	SELL	$219.27 - $242.57 $6,578 - $7,277	-30 Reduced 0.38%	7,823 $1.89 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $212,270 - $248,700	-1,000 Reduced 11.3%	7,853 $1.67 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $213,024 - $236,335	-912 Reduced 9.34%	8,853 $2.16 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $110,955 - $129,300	500 Added 5.4%	9,765 $2.43 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $151,466 - $180,369	-700 Reduced 7.02%	9,265 $2.13 Million
Q3 2020 Oct 28, 2020	SELL	$234.65 - $260.95 $25,811 - $28,704	-110 Reduced 1.09%	9,965 $2.53 Million
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $111,762 - $137,148	-565 Reduced 5.31%	10,075 $2.38 Million
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $61,961 - $82,178	-340 Reduced 3.1%	10,640 $2.16 Million
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $70,953 - $91,200	-375 Reduced 3.3%	10,980 $2.65 Million
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $63,027 - $75,520	-362 Reduced 3.09%	11,355 $2.2 Million
Q2 2019 Jul 24, 2019	SELL	$166.7 - $195.41 $40,008 - $46,898	-240 Reduced 2.01%	11,717 $2.16 Million
Q4 2018 Jan 24, 2019	SELL	$178.4 - $208.25 $62,440 - $72,887	-350 Reduced 2.84%	11,957 $2.33 Million
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $60,219 - $67,889	-325 Reduced 2.57%	12,307 $2.55 Million
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $33,210 - $37,302	-200 Reduced 1.56%	12,632 $2.33 Million
Q1 2018 Apr 24, 2018	SELL	$169.43 - $198.0 $72,007 - $84,150	-425 Reduced 3.21%	12,832 $2.19 Million
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $119,840 - $133,898	-710 Reduced 5.08%	13,257 $2.31 Million
Q3 2017 Oct 26, 2017	BUY	$167.29 - $191.0 $2.34 Million - $2.67 Million	13,967	13,967 $2.6 Million

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

News

Stay updated on Notis Mc Conarty Edward with notifications on news.

Account

Notis Mc Conarty Edward Amgen Inc Transaction History